Neuromodulation Devices Market Size, Industry Trends & Growth Analysis to 2030

Global Neuromodulation Devices Market Size, Share, Trends, Industry Growth by Product Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, Others), by Technology (Internal, External), by Biomaterial, by Application, by End-Use, by Region and Forecast to 2030

Report ID: RC28464 | Report Format: PDF + Excel | Starting Price: 3600/- USD |

Key Findings:

The market is experiencing a significant growth rate of around 10% over the forecast period to 2030
By product type, the spinal cord stimulators segment dominated the market in the benchmark year 2023
Geographically, North America is expected to hold the largest market share by the end of the analysis period to 2030

The global neuromodulation devices market is anticipated to register a significant CAGR of around 10% during the forecast period from 2024 to 2030. The market is primarily driven by the increasing prevalence of neurological disorders such as epilepsy, Parkinson’s disease, and chronic pain, which necessitates advanced therapeutic solutions. Technological advancements, including device miniaturization, improved battery life, and wireless capabilities, have enhanced the efficacy and appeal of neuromodulation devices. The growing geriatric population, who are more susceptible to neurological conditions, further fuels demand. Additionally, the shift towards non-pharmacological treatments due to their fewer side effects, rising healthcare expenditures, favorable reimbursement policies, and greater awareness and acceptance of these therapies contribute to market growth. Collaborations between manufacturers and research institutions, along with regulatory approvals, also play a crucial role in driving the market forward.

Market Snapshot:

Benchmark Year		2023
Market Size
Market Growth (CAGR)		~ 10% (2024 – 2030)
Largest Market Share		North America
Analysis Period		2020-2030
Market Players		Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., and Stimwave Technologies

To know more about the research study, request sample papers

Market Trends:

Technological Advancements: The neuromodulation devices market is benefiting from continuous technological advancements. These include the development of closed-loop systems that can automatically adjust stimulation levels based on real-time feedback from the patient’s physiological signals. This leads to more precise and effective treatment. Additionally, rechargeable devices are becoming more common, which are convenient for patients and reduce the need for frequent surgical interventions to replace batteries. Improved software algorithms are enabling better customization of treatment parameters. These advancements help in fine-tuning the therapy to the individual needs of the patient, thereby enhancing the overall effectiveness of the treatment.

Expansion of Indications: Traditionally, neuromodulation devices were primarily used for treating conditions like chronic pain and movement disorders such as Parkinson’s disease. However, their applications are expanding to include mental health disorders like depression and anxiety, migraines, and even gastrointestinal issues like gastroparesis. This expansion is opening new avenues for market growth and providing more treatment options for patients with a variety of conditions.

Increasing Adoption of Minimally Invasive Procedures: There is a growing trend towards minimally invasive neuromodulation procedures. These procedures are preferred by both patients and healthcare providers because they typically involve less pain, shorter recovery times, and a lower risk of complications compared to traditional open surgeries. As a result, patients can return to their normal activities more quickly, which enhances their overall quality of life.

Integration with Digital Health Technologies: The integration of neuromodulation devices with digital health technologies is revolutionizing patient care. Remote monitoring allows healthcare providers to track patient progress and device performance in real-time, facilitating timely interventions when necessary. Telemedicine enables patients to consult with their healthcare providers without the need for in-person visits, making it easier to manage chronic conditions and adjust treatment plans as needed. Mobile health applications are being used to provide patients with more control over their treatment. These apps can help patients monitor their symptoms, track their treatment progress, and communicate with their healthcare providers, all from the convenience of their smartphones.

Personalized Medicine: Advances in personalized medicine are enabling more tailored neuromodulation therapies. By taking into account individual patient characteristics, such as genetic makeup, lifestyle, and specific medical conditions, healthcare providers can design treatment plans that are more effective and have fewer side effects. This approach not only improves patient outcomes but also enhances patient satisfaction.

Market Opportunities:

The global neuromodulation devices market presents significant opportunities driven by several factors. The growing prevalence of neurological disorders and chronic pain conditions, coupled with advancements in technology, opens avenues for innovative and effective treatments. Expanding applications in mental health, gastrointestinal disorders, and other areas enhance market potential. Additionally, the increasing adoption of minimally invasive procedures and integration with digital health technologies provide opportunities for improved patient outcomes and expanded market reach. Emerging markets, particularly in Asia Pacific and Latin America, offer substantial growth prospects due to improving healthcare infrastructure and rising awareness. Furthermore, collaborations and strategic partnerships among industry players foster innovation and market expansion, while favorable regulatory environments and increased funding support the development and commercialization of advanced neuromodulation devices.

Market Restraints:

Despite its growth potential, the global neuromodulation devices market faces several restraining factors. High costs associated with neuromodulation devices and procedures can limit accessibility for patients, particularly in regions with limited healthcare funding and insurance coverage. Additionally, the complexity of these devices necessitates specialized training for healthcare providers, posing a barrier to widespread adoption. Potential side effects and complications, such as infection or device malfunction, may also deter patients and providers. Regulatory challenges, including stringent approval processes and varying international standards, can delay the introduction of new products. Lastly, limited awareness and acceptance of neuromodulation therapies among patients and healthcare professionals in certain areas can hinder market growth.

Market Insights:

The global neuromodulation devices market is bifurcated into product type, technology, biomaterial, application, end-use, and geography. On the basis of product type, the market is further segmented into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, transcranial magnetic stimulators, and others. The spinal cord stimulators (SCS) segment is the dominant segment in the benchmark year 2023. This dominance is primarily due to the high prevalence of chronic pain conditions, which SCS devices are specifically designed to treat. Chronic pain, often resulting from conditions such as failed back surgery syndrome, complex regional pain syndrome, and other neuropathic pain disorders, affects millions of individuals worldwide. Spinal cord stimulators provide significant relief by disrupting pain signals before they reach the brain, making them a preferred treatment option. Additionally, continuous technological advancements, such as the development of rechargeable and MRI-compatible SCS devices, enhance their appeal by improving patient convenience and expanding the range of eligible patients.

Furthermore, the extensive clinical evidence supporting the efficacy and safety of spinal cord stimulators contributes to their dominant position in the market. Numerous studies have demonstrated that SCS can lead to substantial reductions in pain and improvements in quality of life for patients suffering from chronic pain. This strong clinical validation encourages healthcare providers to adopt these devices more readily. The SCS segment also benefits from robust reimbursement policies in many developed regions, making these devices more accessible to patients. The combination of high demand, technological innovation, clinical effectiveness, and favorable reimbursement conditions solidifies the Spinal Cord Stimulators segment’s leadership in the neuromodulation devices market.

The neuromodulation devices market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.

Historical & Forecast Period

2020-22 – Historical Year
2023 – Base Year
2024-2030 – Forecast Period

Market Segmentation:

By Product Type:

Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Transcranial Magnetic Stimulators
Others

By Technology:

Internal
External

By Biomaterial:

Polymeric Biomaterial
Metallic Biomaterial
Ceramic Biomaterial

By Application:

Application
Parkinson’s Disease
Chronic Pain
Migraine
Epilepsy
Tremor
Depression
Urinary & Faecal Incontinence
Others

By End-Use:

Hospitals & Ambulatory Surgery Centers (ASC)
Clinics & Physiotherapy Centers
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Regional Analysis:

Geographically, North America is the dominant region in the global neuromodulation devices market in the benchmark year 2023. This dominance is driven by several key factors, including the high prevalence of neurological disorders and chronic pain conditions, which significantly boost the demand for neuromodulation therapies. The region also benefits from advanced healthcare infrastructure, which facilitates the widespread adoption and implementation of these sophisticated medical devices. In addition, North America is home to many leading medical device manufacturers and research institutions, fostering a strong environment for innovation and development in neuromodulation technologies.

Moreover, the presence of favorable reimbursement policies in the United States and Canada enhances patient access to neuromodulation devices, further solidifying North America’s leading position. The region’s regulatory framework, characterized by rigorous standards and frequent approvals from the U.S. Food and Drug Administration (FDA), ensures the availability of safe and effective neuromodulation products. Additionally, the growing awareness and acceptance of neuromodulation therapies among patients and healthcare providers, coupled with substantial investments in research and development, continue to drive market growth in North America, making it the most dominant region in this sector.

Competitive Landscape:

Some of the prominent market players operating in the global neuromodulation devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., and Stimwave Technologies. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
NeuroPace, Inc.
Stimwave Technologies
LivaNova PLC
Cyberonics, Inc.
Inspire Medical Systems, Inc.
Bioness Inc.
NeuroSigma, Inc.

Key Questions Answered by Neuromodulation Devices Market Report

Global neuromodulation devices market forecasts from 2024-2030
Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
Neuromodulation devices submarket forecasts from 2024-2030 covering the market by product type, technology, biomaterial, application, end-use, and geography
Various industry models such as SWOT analysis, Value Chain Analysis about the market
Analysis of the key factors driving and restraining the growth of the global, regional, and country-level neuromodulation devices markets from 2024-2030
Competitive Landscape and market positioning of top 10 players operating in the market

Table of Contents:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Neuromodulation Devices Market Portraiture
2.2. Global Neuromodulation Devices Market, by Product Type, 2023 (USD Mn)
2.3. Global Neuromodulation Devices Market, by Technology, 2023 (USD Mn)
2.4. Global Neuromodulation Devices Market, by Biomaterial, 2023 (USD Mn)
2.5. Global Neuromodulation Devices Market, by Application, 2023 (USD Mn)
2.6. Global Neuromodulation Devices Market, by End-Use, 2023 (USD Mn)
2.7. Global Neuromodulation Devices Market, by Geography, 2023 (USD Mn)

3. Global Neuromodulation Devices Market Analysis

3.1. Neuromodulation Devices Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Market Trends
3.5. Attractive Investment Proposition
3.6. Competitive Analysis
3.7. Porter’s Five Force Analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrants
3.7.4. Threat of Substitutes
3.7.5. Degree of Competition
3.8. PESTLE Analysis

4. Global Neuromodulation Devices Market by Product Type, 2020 – 2030 (USD Mn)

4.1. Overview
4.2. Spinal Cord Stimulators
4.3. Deep Brain Stimulators
4.4. Sacral Nerve Stimulators
4.5. Vagus Nerve Stimulators
4.6. Transcranial Magnetic Stimulators
4.7. Others

5. Global Neuromodulation Devices Market by Technology, 2020 – 2030 (USD Mn)

5.1. Overview
5.2. Internal
5.3. External

6. Global Neuromodulation Devices Market by Biomaterial, 2020 – 2030 (USD Mn)

6.1. Overview
6.2. Polymeric Biomaterial
6.3. Metallic Biomaterial
6.4. Ceramic Biomaterial

7. Global Neuromodulation Devices Market by Application, 2020 – 2030 (USD Mn)

7.1. Overview
7.2. Parkinson’s Disease
7.3. Chronic Pain
7.4. Migraine
7.5. Epilepsy
7.6. Tremor
7.7. Depression
7.8. Urinary & Faecal Incontinence
7.9. Others

8. Global Neuromodulation Devices Market by End-Use, 2020 – 2030 (USD Mn)

8.1. Overview
8.2. Hospitals & Ambulatory Surgery Centers (ASC)
8.3. Clinics & Physiotherapy Centers
8.4. Others

9. North America Neuromodulation Devices Market Analysis and Forecast, 2020 – 2030 (USD Mn)

9.1. Overview
9.2. North America Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
9.3. North America Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
9.4. North America Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
9.5. North America Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
9.6. North America Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
9.7. North America Neuromodulation Devices Market by Country, (2020-2030 USD Mn)
9.7.1. U.S.
9.7.1.1. U.S. Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
9.7.1.2. U.S. Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
9.7.1.3. U.S. Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
9.7.1.4. U.S. Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
9.7.1.5. U.S. Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
9.7.2. Canada
9.7.2.1. Canada Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
9.7.2.2. Canada Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
9.7.2.3. Canada Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
9.7.2.4. Canada Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
9.7.2.5. Canada Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
9.7.3. Mexico
9.7.3.1. Mexico Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
9.7.3.2. Mexico Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
9.7.3.3. Mexico Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
9.7.3.4. Mexico Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
9.7.3.5. Mexico Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)

10. Europe Neuromodulation Devices Market Analysis and Forecast, 2020 - 2030 (USD Mn)

10.1. Overview
10.2. Europe Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.3. Europe Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.4. Europe Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.5. Europe Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.6. Europe Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
10.7. Europe Neuromodulation Devices Market by Country, (2020-2030 USD Mn)
10.7.1. Germany
10.7.1.1. Germany Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.7.1.2. Germany Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.7.1.3. Germany Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.7.1.4. Germany Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.7.1.5. Germany Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
10.7.2. U.K.
10.7.2.1. U.K. Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.7.2.2. U.K. Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.7.2.3. U.K. Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.7.2.4. U.K. Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.7.2.5. U.K. Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
10.7.3. France
10.7.3.1. France Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.7.3.2. France Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.7.3.3. France Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.7.3.4. France Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.7.3.5. France Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
10.7.4. Spain
10.7.4.1. Spain Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.7.4.2. Spain Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.7.4.3. Spain Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.7.4.4. Spain Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.7.4.5. Spain Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
10.7.5. Italy
10.7.5.1. Italy Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.7.5.2. Italy Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.7.5.3. Italy Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.7.5.4. Italy Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.7.5.5. Italy Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
10.7.6. Rest of Europe
10.7.6.1. Rest of Europe Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
10.7.6.2. Rest of Europe Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
10.7.6.3. Rest of Europe Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
10.7.6.4. Rest of Europe Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
10.7.6.5. Rest of Europe Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)

11. Asia Pacific Neuromodulation Devices Market Analysis and Forecast, 2020 - 2030 (USD Mn)

11.1. Overview
11.2. Asia Pacific Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
11.3. Asia Pacific Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
11.4. Asia Pacific Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
11.5. Asia Pacific Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
11.6. Asia Pacific Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
11.7. Asia Pacific Neuromodulation Devices Market by Country, (2020-2030 USD Mn)
11.7.1. China
11.7.1.1. China Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
11.7.1.2. China Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
11.7.1.3. China Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
11.7.1.4. China Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
11.7.1.5. China Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
11.7.2. Japan
11.7.2.1. Japan Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
11.7.2.2. Japan Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
11.7.2.3. Japan Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
11.7.2.4. Japan Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
11.7.2.5. Japan Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
11.7.3. India
11.7.3.1. India Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
11.7.3.2. India Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
11.7.3.3. India Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
11.7.3.4. India Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
11.7.3.5. India Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
11.7.4. South Korea
11.7.4.1. South Korea Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
11.7.4.2. South Korea Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
11.7.4.3. South Korea Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
11.7.4.4. South Korea Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
11.7.4.5. South Korea Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
11.7.5. Rest of Asia Pacific
11.7.5.1. Rest of Asia Pacific Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
11.7.5.2. Rest of Asia Pacific Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
11.7.5.3. Rest of Asia Pacific Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
11.7.5.4. Rest of Asia Pacific Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
11.7.5.5. Rest of Asia Pacific Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)

12. Latin America (LATAM) Neuromodulation Devices Market Analysis and Forecast, 2020 - 2030 (USD Mn)

12.1. Overview
12.2. Latin America Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
12.3. Latin America Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
12.4. Latin America Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
12.5. Latin America Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
12.6. Latin America Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
12.7. Latin America Neuromodulation Devices Market by Country, (2020-2030 USD Mn)
12.7.1. Brazil
12.7.1.1. Brazil Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
12.7.1.2. Brazil Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
12.7.1.3. Brazil Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
12.7.1.4. Brazil Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
12.7.1.5. Brazil Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
12.7.2. Argentina
12.7.2.1. Argentina Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
12.7.2.2. Argentina Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
12.7.2.3. Argentina Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
12.7.2.4. Argentina Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
12.7.2.5. Argentina Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
12.7.3. Rest of Latin America
12.7.3.1. Rest of Latin America Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
12.7.3.2. Rest of Latin America Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
12.7.3.3. Rest of Latin America Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
12.7.3.4. Rest of Latin America Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
12.7.3.5. Rest of Latin America Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)

13. Middle East and Africa Neuromodulation Devices Market Analysis and Forecast, 2020 - 2030 (USD Mn)

13.1. Overview
13.2. MEA Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
13.3. MEA Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
13.4. MEA Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
13.5. MEA Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
13.6. MEA Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
13.7. Middle East and Africa Neuromodulation Devices Market, by Country, (2020-2030 USD Mn)
13.7.1. GCC
13.7.1.1. GCC Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
13.7.1.2. GCC Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
13.7.1.3. GCC Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
13.7.1.4. GCC Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
13.7.1.5. GCC Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
13.7.2. South Africa
13.7.2.1. South Africa Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
13.7.2.2. South Africa Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
13.7.2.3. South Africa Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
13.7.2.4. South Africa Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
13.7.2.5. South Africa Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)
13.7.3. Rest of MEA
13.7.3.1. Rest of MEA Neuromodulation Devices Market by Product Type, (2020-2030 USD Mn)
13.7.3.2. Rest of MEA Neuromodulation Devices Market by Technology, (2020-2030 USD Mn)
13.7.3.3. Rest of MEA Neuromodulation Devices Market by Biomaterial, (2020-2030 USD Mn)
13.7.3.4. Rest of MEA Neuromodulation Devices Market by Application, (2020-2030 USD Mn)
13.7.3.5. Rest of MEA Neuromodulation Devices Market by End-Use, (2020-2030 USD Mn)

14. Competitive Landscape

14.1. Company Market Share Analysis, 2023
14.2. Competitive Dashboard
14.3. Competitive Benchmarking
14.4. Geographic Presence Heatmap Analysis
14.5. Company Evolution Matrix
14.5.1. Star
14.5.2. Pervasive
14.5.3. Emerging Leader
14.5.4. Participant
14.6. Strategic Analysis Heatmap Analysis
14.7. Key Developments and Growth Strategies
14.7.1. Mergers and Acquisitions
14.7.2. New Product Launch
14.7.3. Joint Ventures
14.7.4. Others

15. Company Profiles

15.1. Medtronic plc
15.1.1. Business Description
15.1.2. Financial Health and Budget Allocation
15.1.3. Product Positions/Portfolio
15.1.4. Recent Development
15.1.5. SWOT Analysis
15.2. Boston Scientific Corporation
15.3. Abbott Laboratories
15.4. NeuroPace, Inc.
15.5. Stimwave Technologies
15.6. LivaNova PLC
15.7. Cyberonics, Inc.
15.8. Inspire Medical Systems, Inc.
15.9. Bioness Inc.
15.10. NeuroSigma, Inc.

Fill the given form to inquiry before buying for Global Neuromodulation Devices Market Size, Share, Trends, Industry Growth by Product Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, Others), by Technology (Internal, External), by Biomaterial, by Application, by End-Use, by Region and Forecast to 2030 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$ 6995/- Corporate License

For Any Assitance

Email: sales@researchcorridor.com